Effect of transfection of wild-type p53 gene on sensitivity of T cell lymphoma to chemotherapy

LV Fang-fang,HONG Xiao-nan,SHI Bi-zhi,Zonghai Li,Xianghua Wu
DOI: https://doi.org/10.3781/j.issn.1000-7431.2009.04.008
2009-01-01
Tumor
Abstract:Objective:To investigate the effect of exogenous wild type p53 gene transfection on the sensitivity of T lymphocytic lymphoma cell line Jurkat to chemotherapy.Methods:p53-gene was transfected into Jurkat cells by liposome mediation.Jurkat cells with stable expression of exogenous p53 gene were screened by G418.The cell viability was detected by trypan blue exclusion test.Then the cells were exposed to various concentrations of doxorubicin(ADM,0.1-100.0 μg/mL) and etoposide(VP16) for 24 h,and the cell viability was measured by MTT assay.Results:The inhibitory ratio on the proliferation of Jurkat cells with stable expression of exo-genous p53 gene was 50% after treatment with 0.47 μg/mL ADM or 2.5 μg/mL VP16.Compared with the control cells transfected with empty vector or without any transfection,the value of half inhibitory concentration(IC50) was significantly decreased(P<0.05).Conclusion:Expression of p53 could increase the sensitivity of T lymphoma Jurkat cells to ADM and VP16.p53 gene combined with chemotherapy regimen may become a novel approach to treat drug-resistant T lymphoma.
What problem does this paper attempt to address?